Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-088974
Filing Date
2021-07-02
Accepted
2021-07-02 17:03:49
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121284-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121284-7_4seq1.xml 4 4011
  Complete submission text file 0001104659-21-088974.txt   5589
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address
Zaks Tal Zvi (Reporting) CIK: 0001690927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 211071269